Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Aspira Pathlab and Diagnostics Ltd
Your Vote -
Buy
66.67%
Hold
0.00%
Sell
33.33%
66.67%
3 users have voted
Option Chain
Analyzes market sentiment, predicts Aspira Pathlab and Diagnostics Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Aspira Pathlab & Dia - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Aspira Pathlab & Dia - Disclosure Regarding Detailed Public Statement (\DPS\) In Relation To The Open Offer To The Public Sha
-
Aspira Pathlab & Dia - Detailed Public Statement
-
Aspira Pathlab & Dia - Announcement under Regulation 30 (LODR)-Cessation
-
Aspira Pathlab & Dia - Announcement under Regulation 30 (LODR)-Public Announcement-Open Offer
-
Aspira Pathlab & Dia - Announcement under Regulation 30 (LODR)-Change in Directorate
-
Aspira Pathlab & Dia - Appointment Of Secretarial Auditor Of The Company
-
Aspira Pathlab & Dia - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Aspira Pathlab & Dia - Public Announcement - Open Offer
-
Aspira Pathlab & Dia - Shareholder Meeting / Postal Ballot-Outcome of AGM
-
Aspira Pathlab & Dia - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Aspira Pathlab & Dia - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Aspira Pathlab & Dia - Notice Convening 52Nd Annual General Meeting To Be Held On Friday, September 26, 2025 At 02.00 P.M Thr
-
Aspira Pathlab & Dia - Reg. 34 (1) Annual Report.
-
Aspira Pathlab & Dia - Book Closure, Record Date & E-Voting Intimation For The Purpose Of 52Nd Annual General Meeting.
-
Aspira Pathlab & Dia - 52Nd Annual General Meeting To Be Held On Friday, September 26, 2025 At 02.00 P.M (IST) Through Video
-
Aspira Pathlab & Dia posts Q1 net profit of Rs 0.47 cr
-
Aspira Pathlab & Dia - Announcement under Regulation 30 (LODR)-Change in Directorate
-
Aspira Pathlab & Dia - Unaudited Standalone & Consolidated Financial Results For The Quarter Ended June 30, 2025
-
Aspira Pathlab & Dia - Board Meeting Outcome for Outcome Of Board Meeting Held On August 12, 2025
-
Aspira Pathlab & Dia - Board Meeting Intimation for Approval Of Un-Audited Financial Results (Standalone & Consolidated) For
-
Aspira Pathlab & Dia has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2025
-
Aspira Pathlab & Dia - Re-Appointment Of Dr. Pankaj J. Shah (DIN:02836324) As Managing Director & CEO For A Period Of Three (
-
Aspira Pathlab & Dia - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report
Key fundamentals
Evaluate the intrinsic value of Aspira Pathlab and Diagnostics Ltd stock
| Name | March-25 | March-24 | March-23 | March-22 | March-21 |
|---|---|---|---|---|---|
| Assets | 13.4228 | 11.2205 | 13.7122 | 13.6482 | 9.5651 |
| Liabilities | 13.4228 | 11.2205 | 13.7122 | 13.6482 | 9.5651 |
| Equity | 10.293 | 10.293 | 10.293 | 10.293 | 10.293 |
| Gross Profit | 3.5249 | -1.1868 | 1.5932 | 6.3731 | 3.5132 |
| Net Profit | 2.0726 | -2.6722 | -0.0887 | 4.4594 | 1.381 |
| Cash From Operating Activities | 1.8769 | 1.053 | -0.0121 | 2.031 | 5.6734 |
| NPM(%) | 9.42 | -20.23 | -0.61 | 22.81 | 9.08 |
| Revenue | 21.999 | 13.2049 | 14.4569 | 19.5419 | 15.2054 |
| Expenses | 18.4741 | 14.3917 | 12.8637 | 13.1688 | 11.6922 |
| ROE(%) | 17.03 | -21.96 | -0.72 | 36.65 | 11.35 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Aspira Pathlab and Diagnostics Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 789.40 | -1.03 | 71.75 | 35.46 | 301.39 | 0.63 |
| Lotus Eye Hospital and Institute Ltd | 121.00 | -0.12 | 390.77 | 129.23 | 3.55 | 0.00 |
| Bharat Immunological and Biologicals Corporation Ltd | 21.05 | 0.10 | 0.00 | 268.32 | -39.50 | 0.00 |
| Astec Lifesciences Ltd | 773.55 | -1.47 | 0.00 | 121.87 | -604.77 | 0.00 |
Company Info
Aspira Pathlab & Diagnostics Ltd. Was incorporated as 03td July in the year 1973 in the name of 'industrial Gas & Steel Products (India) Ltd.' It has changed its name to 'Utkal Soap Products Ltd.' on 4th February, 1980. USPL with the main object of dealing in gases Products & Steel Products, Subsequent to change of name of the Company, it has changed its object in 1980 to manufacture laundry soaps for Hindustan Lever Limited, having its factory at Sambalput - Orissa. the Company has stopped Manufacturing production since November, 2004 as the job work for Hindustan Lever Limited was not renewed because of additional duties levied by the Government, it has became unviable proposal & the Company has disposed off all its assets in 2005. The employees have been paid off their dues as per settlement with the Labour union, Since 2005.The Company has changed its object clause on 10th August, 2016 & Ventured into diagnostic centers laboratories etc, & stated generating income from December, 2016 onwards. The Company changed its name to 'Aspira Parthlab & Diagnostics Ltd.' on 16th November, 2016.
Aspira Pathlab & Diagnostics Ltd. Was incorporated as 03td July in the year 1973 in the name of 'industrial Gas & Steel Products (India) Ltd.' It has changed its name to 'Utkal Soap Products Ltd.' on 4th February, 1980. USPL with the main object of dealing in gases Products & Steel Products, Subsequent to change of name of the Company, it has changed its object in 1980 to manufacture laundry soaps for Hindustan Lever Limited, having its factory at Sambalput - Orissa. the Company has stopped Manufacturing production since November, 2004 as the job work for Hindustan Lever Limited was not renewed because of additional duties levied by the Government, it has became unviable proposal & the Company has disposed off all its assets in 2005. The employees have been paid off their dues as per settlement with the Labour union, Since 2005.The Company has changed its object clause on 10th August, 2016 & Ventured into diagnostic centers laboratories etc, & stated generating income from December, 2016 onwards. The Company changed its name to 'Aspira Parthlab & Diagnostics Ltd.' on 16th November, 2016.
Read More
Parent Organisation
Aspira Pathlab & Diagnostics Ltd.
Founded
03/07/1973
Managing Director
Dr.Pankaj J Shah
NSE Symbol
FAQ
The current price of Aspira Pathlab and Diagnostics Ltd is
The 52-week high for Aspira Pathlab and Diagnostics Ltd is
The market capitalization of Aspira Pathlab and Diagnostics Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Aspira Pathlab and Diagnostics Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Aspira Pathlab and Diagnostics Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Aspira Pathlab and Diagnostics Ltd shares.
The CEO of Aspira Pathlab and Diagnostics Ltd is Dr.Pankaj J Shah, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
